AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …

Asymptomatic arrhythmias are frequently encountered in clinical practice. Although studies
specifically dedicated to these asymptomatic arrhythmias are lacking, many arrhythmias still …

Background Little is known about the very long term durability of atrial fibrillation (AF)
ablation. Objective The purpose of this study was to evaluate very long term AF ablation …

Aim To investigate the long-term risk of thromboembolism and serious bleeding associated
with oral anticoagulation (OAC) therapy beyond 3 months after radiofrequency ablation …

Electrophysiological and interventional procedures have been increasingly used to reduce
morbidity and mortality in patients experiencing cardiovascular diseases. Although …

Background The optimal long-term antithrombotic regimen for patients after successful
catheter-based atrial fibrillation (AF) ablation is not well defined. Presently, practice variation …

Background There is significant practice variation in oral anticoagulation (OAC) use
following catheter ablation for atrial fibrillation. It is not clear whether the risk of …

Objectives: The aim of this study was to perform a collaborative meta-analysis of published
and unpublished quality-of-life, morbidity, and mortality data from randomized controlled trial …

Background Anticoagulation in patients with atrial fibrillation (AF) is currently based on
clinical parameters (CHA2DS 2‐VASc score) that have been shown to predict …

Background Stroke is the major cause of morbidity and mortality related to atrial fibrillation
(AF). Catheter ablation for AF is effective in reducing AF burden, but its impact on long-term …